Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 999 892 240

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

menu
Contact InfoCenter Career DE
EN

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

05.12.2023 - 06.12.2023

EACR-AstraZeneca Cancer Epigenetics

Location
Virtual event (worldwide access)
Contact

Hannah Barrs <hannah.barrs@eacr.org>

Country
United Kingdom
Subject area(s)
Cell Biology, Pharmacology and Toxicology, Pathology, Oncology, Molecular- and Cellbiology, Microbiology, Immunology, Genetics and Genetic Technology, Clinical Research, Life Science, Medicine, Molecular Medicine, Biomedicine, Systemic Therapy, Life sciences, Biology
Shortinfo

Epigenetic control is essential for development and differentiation, and this control mechanism is very frequently deregulated in cancer. Several small molecule inhibitors have been developed in recent years that have either been approved for clinical use or are in preclinical and clinical trials. This conference will focus on basic and clinical aspects of targeting a broad panel of epigenetic proteins in cancer, either as monotherapies, or as combination therapies, including the use of immune checkpoint inhibitors to increase drug sensitivity and overcome chemoresistance.



Topics to be covered include epigenetic regulation in cancer development and maintenance, novel epigenetic targets, drug resistance, combination therapies, and applications in clinical trials. The target audience for this virtual conference is scientists in both academia and industry who are interested in how epigenetic targeted therapy can be used for genetically targeted and combination therapies, including immune-based cancer therapies. The conference will focus on the mechanistic aspects of gene regulation and cellular plasticity, drug development as well as clinical trials using epigenetic targeted therapies.



Speakers: Ho Man Chan (Head of Epigenetics, Research, & Development: AstraZeneca, USA), Mark Dawson (Peter MacCallum Cancer Center, Australia), Ernesto Guccione (Icahn School of Medicine at Mount Sinai, USA), Kristian Helin (The Institute of Cancer Research, UK), Ricky Johnstone (Peter MacCallum Cancer Center, Australia), Cigall Kadoch (Harvard Medical School, USA), Melissa B. Pappalardi (GSK, USA), Oliver Raush (Storm Therapeutics, UK), Eytan Stein (MSKCC, USA), Celine Vallot (Institut Curie, France), Jingwen Zhang (Associate Director: AstraZeneca, USA)



Keywords: epigenetics, molecule inhibitors, epigenetic proteins in cancer, monotherapies, combination therapies, immune checkpoint inhibitors, drug discovery, drug sensitivity, chemoresistance, genetically targeted cancer therapy, novel epigenetic targets, drug resistance, clinical cancer trials, cancer research, oncology



Deadlines:


Abstract submission deadline: 09 October 2023


Registration deadline: 13 November 2023

 
Website
Back to list

ZB MED is supported by the Federal Ministry of Health

ZB MED is supported by the Federal Ministry of Health.

The Federal Ministry of Health is a sponsor of ZB MED on the basis of a decision by the German Bundestag.

Local universities cooperate closely with ZB MED as partners

Logo of University Cologne

The robust, well-established partnership between ZB MED and the University of Cologne covers research, teaching and the provision of information. The Scientific Director of ZB MED also holds a professorship at the Medical Faculty.

ZB MED is sponsered by the Ministry of Culture and Science of North Rhine-Westphalia

Logo of Ministry of Culture and Science of the German State of North Rhine-Westphalia
Logo of Ministry of Culture and Science of the German State of North Rhine-Westphalia

The Ministry of Culture and Science of the German State of North Rhine-Westphalia is sponsoring ZB MED.

Local universities cooperate closely with ZB MED as partners

Logo University Bonn

A joint professorship is just one example of the cooperation between ZB MED and the University of Bonn in the fields of research and teaching. ZB MED’s Bonn site is located on the Poppelsdorf campus.

ZB MED advocates Open Access

ZB MED promotes and supports open access to scientific research through the PUBLISSO portal and other services.

Local universities cooperate closely with ZB MED as partners

ZB MED’s cooperation with TH Köln focuses on providing qualifications in information and data science through joint professorships and other strategies.

ZB MED is a member of DataCite

DataCite Logo

DataCite is an international not-for-profit organisation that offers services and know-how relating to the management, referencing and citation of research data.

ZB MED and Bielefeld University have signed a cooperation agreement

Logo University Bielefeld

The objective is to work together to provide complementary information services for the life sciences.

ZB MED advocates equality

ZB MED received the TOTAL E-QUALITY award in 2010, 2013, 2017 and 2021 for successfully implementing equality in its staffing structure and personnel policies.

ZB MED is one of over 30 partners in the LFV Open Science

The network is committed to the research and development of working methods, infrastructures, and tools of Open Science.

ZB MED is a member of DAFA.

The "Deutsche Agrarfoschungsallianz" aims to improve the performance, transparency and international visibility of German agricultural research. It is a joint project of German agricultural research.

ZB MED is committed to the principles of Libraries4Future.

Climate protection, sustainability, responsibility, social solidarity.